Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630239 · ClinicalTrials.gov registry record · Early Phase 1
MR-Guided Laser Ablation of Hepatic Tumors
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT01630239: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT01630239 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01630239, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a pilot study to investigate the performance of MR-guided Laser Induced Thermal Therapy (LITT) in the treatment of liver tumors.
Interventions
- PROCEDURE Laser ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01630239
The ClinicalTrials.gov registry entry for NCT01630239 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Laser ablation is the first listed.
NCT01630239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01630239 about?
NCT01630239 is a clinical study titled "MR-Guided Laser Ablation of Hepatic Tumors". This is a pilot study to investigate the performance of MR-guided Laser Induced Thermal Therapy (LITT) in the treatment of liver tumors.
What is the current status of trial NCT01630239?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2012-06. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01630239?
The interventions under investigation include: Laser ablation (PROCEDURE).
Who is sponsoring clinical trial NCT01630239?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.